| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 17 Jun 24 | ADVM Adverum Biotechnologies | Stock Option Common Stock | Grant | Acquire A | No | No | 7.32 | 85,000 | 622.20 k | 85,000 |
| 5 Feb 24 | OCUL Ocular Therapeutix | Common Stock | Sell | Acquire S | No | No | 4.86 | 6,346 | 30.84 k | 153,054 |
| 3 Feb 24 | OCUL Ocular Therapeutix | Common Stock | Grant | Acquire A | No | No | 0 | 66,633 | 0.00 | 159,400 |
| 3 Feb 24 | OCUL Ocular Therapeutix | Stock Option Common Stock | Grant | Acquire A | No | No | 5.18 | 200,000 | 1.04 mm | 200,000 |
| 31 Jan 24 | OCUL Ocular Therapeutix | Common Stock | Sell | Dispose S | No | No | 4.95 | 7,764 | 38.43 k | 92,767 |
| 7 Jul 23 | OCUL Ocular Therapeutix | Common Stock | Sell | Dispose S | No | No | 4.93 | 832 | 4.10 k | 100,531 |
